Wenlai Zhou
15Patents
3h-index
29Co-inventors
56Inventor score
Filing activity: Apr 11, 2007 → Apr 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8293718B2 | Organic compositions to treat HSF1-related diseases | Emerging Cross-Sectional Technologies | 5 | Active |
| US8623838B2 | Organic compositions to treat HSF1-related diseases | Emerging Cross-Sectional Technologies | 5 | Active |
| US8481509B2 | Organic compositions to treat HSF1-related diseases | Chemistry; Metallurgy | 5 | Active |
| US10287582B2 | Organic compositions to treat HSF1-related diseases | Emerging Cross-Sectional Technologies | 2 | Active |
| US9096637B2 | Organic compositions to treat HSF1-related diseases | Emerging Cross-Sectional Technologies | 2 | Active |
| US9540643B2 | Organic compositions to treat HSF1-related diseases | Emerging Cross-Sectional Technologies | 2 | Active |
| US11174319B2 | Binding molecule specific for CD73 and use of binding molecule | Chemistry; Metallurgy | 0 | Active |
| US12391756B2 | Binding molecule specific for CD39 and use thereof | Chemistry; Metallurgy | 0 | Active |
| US7981615B2 | Compositions and methods for treating diseases associated with T-box and N-Myc | Physics | 0 | Active |
| US10011874B2 | Androgen receptor mutation | Physics | 0 | Active |
| US7625874B2 | Compositions and methods for treating diseases associated with T-box and N-Myc | Physics | 0 | Active |
| US11091761B2 | Organic compositions to treat HSF1-related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US12281168B2 | Binding molecule specific for LIF and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10329563B2 | Organic compositions to treat HSF1-related diseases | Chemistry; Metallurgy | 0 | Active |
| US12091661B2 | Organic compositions to treat HSF1-related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.